Gritstone Bio GRTS is a clinical-stage biotechnology company focused on developing vaccines targeting multiple indications, including cancer. In the past week, the company’s stock lost 57.5%. This ...
Gritstone bio Inc. (GRTS) has been beaten down lately with too much selling pressure. While the stock has lost 63.4% over the past four weeks, there is light at the end of the tunnel as it is now in ...
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of Gritstone bio, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results